National Penn Investors Trust’s GSK GSK Stock Holding History

National Penn Investors Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$405K	Sell	7,998 -9,519	-54%	-$474K	0.05%	148
2015 Q4	$884K	Hold	17,517	–	–	0.1%	121
2015 Q3	$841K	Sell	17,517 -520	-3%	-$27.1K	0.1%	120
2015 Q2	$939K	Hold	18,037	–	–	0.1%	121
2015 Q1	$1.04M	Sell	18,037 -380	-2%	-$21.8K	0.11%	114
2014 Q4	$984K	Hold	18,417	–	–	0.11%	110
2014 Q3	$1.06M	Hold	18,417	–	–	0.12%	103
2014 Q2	$1.23M	Sell	18,417 -140	-0.8%	-$9.48K	0.14%	99
2014 Q1	$1.24M	Sell	18,557 -680	-4%	-$46K	0.15%	101
2013 Q4	$1.28M	Sell	19,237 -80	-0.4%	-$5.19K	0.14%	108
2013 Q3	$1.21M	Sell	19,317 -160	-0.8%	-$10.3K	0.15%	111
2013 Q2	$1.22M	Buy	+19,477	New	+$1.24M	0.16%	114

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

National Penn Investors Trust's GSK Position: Q1 2016 in Review

National Penn Investors Trust reduced its GSK (GSK) stake by 54% in Q1 2016, selling an estimated $474K and leaving 7,998 shares worth $405K. The position accounts for 0.05% of the portfolio, ranked #148.

National Penn Investors Trust first reported a position in GSK in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.28M in Q4 2013. 727 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

National Penn Investors Trust held 7,998 shares of GSK worth $405K as of Q1 2016.
National Penn Investors Trust sold 9,519 GSK shares in Q1 2016, an estimated $474K.
GSK made up 0.05% of National Penn Investors Trust's portfolio in Q1 2016, its #148 holding.
National Penn Investors Trust first reported a position in GSK in Q2 2013 and has held it in 12 quarters since.
National Penn Investors Trust's GSK position peaked at $1.28M in Q4 2013.
727 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.